Abstract
Background: Chronic systemic inflammation may contribute to accelerated atherosclerosis and increased arterial stiffness in patients with rheumatoid arthritis (RA). In addition to lowering cholesterol, statins have immunomodulatory effects which may be especially beneficial in patients with RA who have systemic immune activation.
Objective: To investigate the effect of atorvastatin on the augmentation index (AIx: a measure of arterial stiffness) and systemic inflammation in RA.
Methods: 29 patients with RA (mean (SD) age 55 (13) years) with moderately active disease of long duration were studied. AIx, lipid levels, serum inflammatory markers, and disease activity score were measured before and after 12 weeks of atorvastatin 20 mg daily.
Results: AIx improved significantly from 34.1 (11.6)% to 29.9 (11)% (p = 0.0002), with the greatest improvements in AIx occurring in those subjects with the highest disease activity scores (r = –0.5, p = 0.007). Total and LDL cholesterol were reduced from 5.5 (0.9) to 3.9 (0.7) mmol/l and 3.3 (0.8) to 1.9 (0.6) mmol/l, respectively (p = 0.0001). Serum inflammatory markers remained unchanged during the study.
Conclusions: Atorvastatin significantly reduced arterial stiffness in patients with RA. The greatest improvements were seen in patients with more active disease, suggesting that, in addition to the beneficial effects of cholesterol reduction, immune modulation may contribute to the cardioprotective effect of statins.
Full Text
The Full Text of this article is available as a PDF (81.9 KB).
Figure 1.
Relationship between baseline DAS28 and change in AIx with atorvastatin.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aikawa M., Rabkin E., Sugiyama S., Voglic S. J., Fukumoto Y., Furukawa Y., Shiomi M., Schoen F. J., Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001 Jan 16;103(2):276–283. doi: 10.1161/01.cir.103.2.276. [DOI] [PubMed] [Google Scholar]
- Albert M. A., Danielson E., Rifai N., Ridker P. M., PRINCE Investigators Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001 Jul 4;286(1):64–70. doi: 10.1001/jama.286.1.64. [DOI] [PubMed] [Google Scholar]
- Alfon J., Pueyo Palazon C., Royo T., Badimon L. Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model. Thromb Haemost. 1999 May;81(5):822–827. [PubMed] [Google Scholar]
- Arnett D. K., Evans G. W., Riley W. A. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol. 1994 Oct 15;140(8):669–682. doi: 10.1093/oxfordjournals.aje.a117315. [DOI] [PubMed] [Google Scholar]
- Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
- Avolio A., Jones D., Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in the arterial media. Hypertension. 1998 Jul;32(1):170–175. doi: 10.1161/01.hyp.32.1.170. [DOI] [PubMed] [Google Scholar]
- Bacon P. A., Raza K., Banks M. J., Townend J., Kitas G. D. The role of endothelial cell dysfunction in the cardiovascular mortality of RA. Int Rev Immunol. 2002 Jan-Feb;21(1):1–17. doi: 10.1080/08830180210413. [DOI] [PubMed] [Google Scholar]
- Bank A. J., Kaiser D. R., Rajala S., Cheng A. In vivo human brachial artery elastic mechanics: effects of smooth muscle relaxation. Circulation. 1999 Jul 6;100(1):41–47. doi: 10.1161/01.cir.100.1.41. [DOI] [PubMed] [Google Scholar]
- Bank A. J., Wang H., Holte J. E., Mullen K., Shammas R., Kubo S. H. Contribution of collagen, elastin, and smooth muscle to in vivo human brachial artery wall stress and elastic modulus. Circulation. 1996 Dec 15;94(12):3263–3270. doi: 10.1161/01.cir.94.12.3263. [DOI] [PubMed] [Google Scholar]
- Bellosta S., Via D., Canavesi M., Pfister P., Fumagalli R., Paoletti R., Bernini F. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1671–1678. doi: 10.1161/01.atv.18.11.1671. [DOI] [PubMed] [Google Scholar]
- Bergholm Robert, Leirisalo-Repo Marjatta, Vehkavaara Satu, Mäkimattila Sari, Taskinen Marja-Riitta, Yki-Järvinen Hannele. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1637–1641. doi: 10.1161/01.atv.0000033516.73864.4e. [DOI] [PubMed] [Google Scholar]
- Bocan T. M., Mazur M. J., Mueller S. B., Brown E. Q., Sliskovic D. R., O'Brien P. M., Creswell M. W., Lee H., Uhlendorf P. D., Roth B. D. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation. Atherosclerosis. 1994 Nov;111(1):127–142. doi: 10.1016/0021-9150(94)90198-8. [DOI] [PubMed] [Google Scholar]
- Boutouyrie Pierre, Tropeano Anne Isabelle, Asmar Roland, Gautier Isabelle, Benetos Athanase, Lacolley Patrick, Laurent Stéphane. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002 Jan;39(1):10–15. doi: 10.1161/hy0102.099031. [DOI] [PubMed] [Google Scholar]
- Collins Rory, Armitage Jane, Parish Sarah, Sleigh Peter, Peto Richard, Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003 Jun 14;361(9374):2005–2016. doi: 10.1016/s0140-6736(03)13636-7. [DOI] [PubMed] [Google Scholar]
- Dobrucki L. W., Kalinowski L., Dobrucki I. T., Malinski T. Statin-stimulated nitric oxide release from endothelium. Med Sci Monit. 2001 Jul-Aug;7(4):622–627. [PubMed] [Google Scholar]
- Ferrier Kathryn E., Muhlmann Michael H., Baguet Jean Philippe, Cameron James D., Jennings Garry L., Dart Anthony M., Kingwell Bronwyn A. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol. 2002 Mar 20;39(6):1020–1025. doi: 10.1016/s0735-1097(02)01717-5. [DOI] [PubMed] [Google Scholar]
- Fukumoto Y., Libby P., Rabkin E., Hill C. C., Enomoto M., Hirouchi Y., Shiomi M., Aikawa M. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation. 2001 Feb 20;103(7):993–999. doi: 10.1161/01.cir.103.7.993. [DOI] [PubMed] [Google Scholar]
- Grey Elizabeth, Bratteli Chris, Glasser Stephen P., Alinder Cheryl, Finkelstein Stanley M., Lindgren Bruce R., Cohn Jay N. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens. 2003 Apr;16(4):265–269. doi: 10.1016/s0895-7061(02)03271-5. [DOI] [PubMed] [Google Scholar]
- Hernández-Perera O., Pérez-Sala D., Navarro-Antolín J., Sánchez-Pascuala R., Hernández G., Díaz C., Lamas S. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest. 1998 Jun 15;101(12):2711–2719. doi: 10.1172/JCI1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hidaka Y., Eda T., Yonemoto M., Kamei T. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733). Atherosclerosis. 1992 Jul;95(1):87–94. doi: 10.1016/0021-9150(92)90179-k. [DOI] [PubMed] [Google Scholar]
- Hürlimann David, Forster Adrian, Noll Georg, Enseleit Frank, Chenevard Rémy, Distler Oliver, Béchir Markus, Spieker Lukas E., Neidhart Michel, Michel Beat A. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002 Oct 22;106(17):2184–2187. doi: 10.1161/01.cir.0000037521.71373.44. [DOI] [PubMed] [Google Scholar]
- Ichihara Atsuhiro, Hayashi Matsuhiko, Ryuzaki Munekazu, Handa Michiko, Furukawa Tomohiro, Saruta Takao. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant. 2002 Aug;17(8):1513–1517. doi: 10.1093/ndt/17.8.1513. [DOI] [PubMed] [Google Scholar]
- Ikeda U., Shimpo M., Ohki R., Inaba H., Takahashi M., Yamamoto K., Shimada K. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Hypertension. 2000 Sep;36(3):325–329. doi: 10.1161/01.hyp.36.3.325. [DOI] [PubMed] [Google Scholar]
- Inoue I., Goto S., Mizotani K., Awata T., Mastunaga T., Kawai S., Nakajima T., Hokari S., Komoda T., Katayama S. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells. Life Sci. 2000 Jul 14;67(8):863–876. doi: 10.1016/s0024-3205(00)00680-9. [DOI] [PubMed] [Google Scholar]
- Kinlay S., Creager M. A., Fukumoto M., Hikita H., Fang J. C., Selwyn A. P., Ganz P. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension. 2001 Nov;38(5):1049–1053. doi: 10.1161/hy1101.095329. [DOI] [PubMed] [Google Scholar]
- Kontopoulos Athanasios G., Athyros Vasilios G., Pehlivanidis Anthimos N., Demitriadis Dimokritos S., Papageorgiou Athanasios A., Boudoulas Harisios. Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients. Curr Med Res Opin. 2003;19(1):22–27. doi: 10.1185/030079902125001290. [DOI] [PubMed] [Google Scholar]
- Laufs U., Marra D., Node K., Liao J. K. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1). J Biol Chem. 1999 Jul 30;274(31):21926–21931. doi: 10.1074/jbc.274.31.21926. [DOI] [PubMed] [Google Scholar]
- Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., Ducimetiere P., Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001 May;37(5):1236–1241. doi: 10.1161/01.hyp.37.5.1236. [DOI] [PubMed] [Google Scholar]
- Leung Bernard P., Sattar Naveed, Crilly Anne, Prach Morag, McCarey David W., Payne Helen, Madhok Rajan, Campbell Carol, Gracie J. Alastair, Liew Foo Y. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol. 2003 Feb 1;170(3):1524–1530. doi: 10.4049/jimmunol.170.3.1524. [DOI] [PubMed] [Google Scholar]
- Li Jian-Jun, Chen Xue-Jun. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide. Coron Artery Dis. 2003 Jun;14(4):329–334. doi: 10.1097/01.mca.0000078062.22445.60. [DOI] [PubMed] [Google Scholar]
- McVeigh G. E., Allen P. B., Morgan D. R., Hanratty C. G., Silke B. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (Lond) 2001 Apr;100(4):387–393. [PubMed] [Google Scholar]
- McVeigh G. E., Burns D. E., Finkelstein S. M., McDonald K. M., Mock J. E., Feske W., Carlyle P. F., Flack J., Grimm R., Cohn J. N. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens. 1991 Mar;4(3 Pt 1):245–251. doi: 10.1093/ajh/4.3.245. [DOI] [PubMed] [Google Scholar]
- McVeigh G. E., Morgan D. J., Finkelstein S. M., Lemay L. A., Cohn J. N. Vascular abnormalities associated with long-term cigarette smoking identified by arterial waveform analysis. Am J Med. 1997 Mar;102(3):227–231. doi: 10.1016/S0002-9343(96)00454-8. [DOI] [PubMed] [Google Scholar]
- McVeigh G., Brennan G., Hayes R., Cohn J., Finkelstein S., Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med. 1993 Oct;95(4):424–430. doi: 10.1016/0002-9343(93)90313-e. [DOI] [PubMed] [Google Scholar]
- Morikawa Shigeru, Takabe Wakako, Mataki Chikage, Kanke Toru, Itoh Takahiro, Wada Youichiro, Izumi Akashi, Saito Yasushi, Hamakubo Takao, Kodama Tatsuhiko. The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. J Atheroscler Thromb. 2002;9(4):178–183. doi: 10.5551/jat.9.178. [DOI] [PubMed] [Google Scholar]
- Nègre-Aminou P., van Vliet A. K., van Erck M., van Thiel G. C., van Leeuwen R. E., Cohen L. H. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. Biochim Biophys Acta. 1997 Apr 21;1345(3):259–268. doi: 10.1016/s0005-2760(96)00184-1. [DOI] [PubMed] [Google Scholar]
- O'Driscoll G., Green D., Taylor R. R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation. 1997 Mar 4;95(5):1126–1131. doi: 10.1161/01.cir.95.5.1126. [DOI] [PubMed] [Google Scholar]
- Oliver James J., Webb David J. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003 Feb 6;23(4):554–566. doi: 10.1161/01.ATV.0000060460.52916.D6. [DOI] [PubMed] [Google Scholar]
- Pahan K., Sheikh F. G., Namboodiri A. M., Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest. 1997 Dec 1;100(11):2671–2679. doi: 10.1172/JCI119812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parker Rex A., Huang Qi, Tesfamariam Belay. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature. Atherosclerosis. 2003 Jul;169(1):19–29. doi: 10.1016/s0021-9150(03)00100-x. [DOI] [PubMed] [Google Scholar]
- Pasceri V., Yeh E. T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation. 1999 Nov 23;100(21):2124–2126. doi: 10.1161/01.cir.100.21.2124. [DOI] [PubMed] [Google Scholar]
- Ridker P. M., Rifai N., Clearfield M., Downs J. R., Weis S. E., Miles J. S., Gotto A. M., Jr, Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001 Jun 28;344(26):1959–1965. doi: 10.1056/NEJM200106283442601. [DOI] [PubMed] [Google Scholar]
- Ridker P. M., Rifai N., Pfeffer M. A., Sacks F. M., Moye L. A., Goldman S., Flaker G. C., Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1998 Sep 1;98(9):839–844. doi: 10.1161/01.cir.98.9.839. [DOI] [PubMed] [Google Scholar]
- Ridker P. M., Rifai N., Pfeffer M. A., Sacks F., Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999 Jul 20;100(3):230–235. doi: 10.1161/01.cir.100.3.230. [DOI] [PubMed] [Google Scholar]
- Rietzschel E. R., Boeykens E., De Buyzere M. L., Duprez D. A., Clement D. L. A comparison between systolic and diastolic pulse contour analysis in the evaluation of arterial stiffness. Hypertension. 2001 Jun;37(6):E15–E22. doi: 10.1161/01.hyp.37.6.e15. [DOI] [PubMed] [Google Scholar]
- Sakai M., Kobori S., Matsumura T., Biwa T., Sato Y., Takemura T., Hakamata H., Horiuchi S., Shichiri M. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis. 1997 Aug;133(1):51–59. doi: 10.1016/s0021-9150(97)00118-4. [DOI] [PubMed] [Google Scholar]
- Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
- Takemoto M., Liao J. K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1712–1719. doi: 10.1161/hq1101.098486. [DOI] [PubMed] [Google Scholar]
- Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997 Jan 7;95(1):76–82. doi: 10.1161/01.cir.95.1.76. [DOI] [PubMed] [Google Scholar]
- Van Doornum S., McColl G., Jenkins A., Green D. J., Wicks I. P. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum. 2003 Jan;48(1):72–80. doi: 10.1002/art.10735. [DOI] [PubMed] [Google Scholar]
- Van Doornum S., McColl G., Wicks I. P. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002 Apr;46(4):862–873. doi: 10.1002/art.10089. [DOI] [PubMed] [Google Scholar]
- Vaughan C. J., Murphy M. B., Buckley B. M. Statins do more than just lower cholesterol. Lancet. 1996 Oct 19;348(9034):1079–1082. doi: 10.1016/S0140-6736(96)05190-2. [DOI] [PubMed] [Google Scholar]
- Wilkinson I. B., Fuchs S. A., Jansen I. M., Spratt J. C., Murray G. D., Cockcroft J. R., Webb D. J. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens. 1998 Dec;16(12 Pt 2):2079–2084. doi: 10.1097/00004872-199816121-00033. [DOI] [PubMed] [Google Scholar]
- Wilkinson Ian B., MacCallum Helen, Cockcroft John R., Webb David J. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol. 2002 Feb;53(2):189–192. doi: 10.1046/j.1365-2125.2002.1528adoc.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson Ian B., Prasad Krishna, Hall Ian R., Thomas Anne, MacCallum Helen, Webb David J., Frenneaux Michael P., Cockcroft John R. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002 Mar 20;39(6):1005–1011. doi: 10.1016/s0735-1097(02)01723-0. [DOI] [PubMed] [Google Scholar]
- Yang Z., Kozai T., van der Loo B., Viswambharan H., Lachat M., Turina M. I., Malinski T., Lüscher T. F., van de Loo B. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. J Am Coll Cardiol. 2000 Nov 1;36(5):1691–1697. doi: 10.1016/s0735-1097(00)00924-4. [DOI] [PubMed] [Google Scholar]
- van Popele N. M., Grobbee D. E., Bots M. L., Asmar R., Topouchian J., Reneman R. S., Hoeks A. P., van der Kuip D. A., Hofman A., Witteman J. C. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001 Feb;32(2):454–460. doi: 10.1161/01.str.32.2.454. [DOI] [PubMed] [Google Scholar]
- van der Heijde D. M., van't Hof M. A., van Riel P. L., van Leeuwen M. A., van Rijswijk M. H., van de Putte L. B. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis. 1992 Feb;51(2):177–181. doi: 10.1136/ard.51.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]